SNDX•benzinga•
Syndax Pharmaceuticals FY2024 R&D expenses forecast: $245M-$250M.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 5, 2024 by benzinga